is 741 has been researched along with Pancreatitis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manabe, T | 1 |
| Kuroda, Y; Takase, K; Ueda, T | 1 |
| Haga, T; Kimura, H; Shigehara, I; Sugi, H; Yotsuya, S; Yuki, S | 1 |
| Kato, M; Koga, Y; Nakano, I; Sakai, K; Shikama, H; Sugi, H; Takada, H; Yotsuya, S | 1 |
| Akizuki, E; Ishihara, K; Liang, J; Matsuda, T; Matsumura, F; Nakano, S; Ogawa, M; Ohshiro, H; Okabe, K; Yamaguchi, Y | 2 |
| Bassi, C | 1 |
| Iovanna, JL; Motoo, Y; Sawabu, N; Su, SB; Xie, MJ | 1 |
2 review(s) available for is 741 and Pancreatitis
| Article | Year |
|---|---|
[New aspects of pharmaco-therapy for acute pancreatitis].
Topics: Acute Disease; Animals; Blood Proteins; Clinical Trials as Topic; Drug Design; Humans; Imidazoles; Leucine; Octreotide; Pancreatitis; Platelet Activating Factor; Proglumide; Pyridines; Receptor, Cholecystokinin A; Somatostatin | 2004 |
IS-741 (Ishihara Sangyo).
Topics: Animals; Clinical Trials as Topic; Enzyme Inhibitors; Humans; Pancreatitis; Phospholipases A; Phospholipases A2; Pyridines; Structure-Activity Relationship | 2001 |
6 other study(ies) available for is 741 and Pancreatitis
| Article | Year |
|---|---|
Current aspects of the pathophysiology of acute pancreatitis and therapeutic effects of an inflammatory cell infiltration inhibitor.
Topics: Acute Disease; Humans; Inflammation; Interleukin-8; Pancreatitis; Phospholipases A; Pyridines | 2003 |
Synthesis and antipancreatitis activities of novel N-(2-sulfonylamino-5-trifluoromethyl-3-pyridyl)carboxamide derivatives as phospholipase A2 inhibitors.
Topics: Acute Disease; Amides; Animals; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Male; Pancreatitis; Phospholipases A; Phospholipases A2; Pyridines; Rats; Rats, Sprague-Dawley | 1995 |
A novel synthetic anti-acute pancreatitis agent, IS-741.
Topics: Acute Disease; Animals; Cell Adhesion; Cell Line; Disease Models, Animal; Enzyme Inhibitors; Neutrophil Infiltration; Pancreatitis; Pyridines; Rats | 1999 |
The novel carboxamide derivative IS-741 reduces neutrophil chemoattractant production by bronchoalveolar macrophages in rats with cerulein-induced pancreatitis complicated by sepsis.
Topics: Animals; CD18 Antigens; Ceruletide; Chemotaxis; Disease Models, Animal; Enzyme Inhibitors; Injections, Intravenous; Interleukin-8; Macrophage-1 Antigen; Macrophages, Alveolar; Male; Neutrophil Infiltration; Pancreatitis; Pyridines; Rats; Rats, Wistar; Sepsis | 1999 |
Novel carboxamide derivative (IS-741) attenuates lung injury in rats with cerulein-induced pancreatitis complicated by endotoxemia.
Topics: Acute Disease; Animals; Bronchoalveolar Lavage Fluid; Cells, Cultured; Ceruletide; Endotoxemia; Enzyme Inhibitors; Hemorrhage; Infusions, Intravenous; Interleukin-16; Lung; Lung Diseases; Macrophages; Male; Neutrophils; Pancreatitis; Phospholipases A; Pyridines; Rats; Rats, Sprague-Dawley | 1999 |
Effect of carboxamide derivative IS-741 on rat spontaneous chronic pancreatitis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Chronic Disease; Immunohistochemistry; Interleukin-6; Interleukin-8; Male; Pancreatitis; Pancreatitis-Associated Proteins; Polymerase Chain Reaction; Propiophenones; Pyridines; Rats | 2002 |